Page last updated: 2024-08-23

mifepristone and Adenoma

mifepristone has been researched along with Adenoma in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (37.50)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Biller, BMK; Tritos, NA	1
Ayala, A; Biller, BMK; Bonert, V; Broder, MS; Carmichael, JD; Cherepanov, D; Eagan, M; Geer, EB; Gordon, MB; Hannoush, Z; Katznelson, L; Lalazar, Y; Lee, J; Manuylova, E; Neary, MP; Pulaski-Liebert, KJ; Said, Q; Shafiq, I; Surampudi, V; Swerdloff, RS	1
Arumugam, D; Belokovskaya, R; Geer, EB; Goddard, GM; Izadmehr, S; Levine, AC; Ravikumar, A	1
Buchfelder, M; Findling, JW; Fleseriu, M; Gross, C; Koch, CA; Schlaffer, SM	1
Barahona Constanzo, MJ; del Pozo Picó, C	1
Bons, EG; Lamberts, SW; Uitterlinden, P	1
Gompel, A; Kuttenn, F; Mauvais-Jarvis, P	1
Den, K; Ohtani, K; Sakamoto, H; Suzuki, H; Takagi, S; Takahashi, T; Watanabe, Y	1

Reviews

3 review(s) available for mifepristone and Adenoma

Article	Year
Advances in the Medical Treatment of Cushing Disease. Endocrinology and metabolism clinics of North America, 2020, Volume: 49, Issue:3 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Cabergoline; Endocrinology; Humans; Mifepristone; Mitotane; Pituitary ACTH Hypersecretion; Somatostatin; Treatment Outcome	2020
New prospects for drug treatment in Cushing disease. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:10 Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cabergoline; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Ergolines; Etomidate; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Mice; Mifepristone; Mitotane; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; PPAR gamma; Pyridines; Rats; Somatostatin; Therapies, Investigational; Tretinoin	2012
Antiestrogen action of progesterone in breast tissue. Breast cancer research and treatment, 1986, Volume: 8, Issue:3 Topics: 17-Hydroxysteroid Dehydrogenases; Adenoma; Animals; Breast; Cell Division; Cells, Cultured; Estradiol; Estrenes; Estrogen Antagonists; Estrogens; Female; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mifepristone; Progesterone; Progestins; Promegestone; Receptors, Estrogen	1986

Trials

1 trial(s) available for mifepristone and Adenoma

Article	Year
Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:10 Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Corticotrophs; Female; Hormone Antagonists; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Middle Aged; Mifepristone; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Prospective Studies; Receptors, Glucocorticoid	2014

Article

Year

Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone.

The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:10

Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Corticotrophs; Female; Hormone Antagonists; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Middle Aged; Mifepristone; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Prospective Studies; Receptors, Glucocorticoid

2014

Other Studies

4 other study(ies) available for mifepristone and Adenoma

Article	Year
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:8 Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenalectomy; Adult; Aged; Antineoplastic Agents; Cabergoline; Comorbidity; Enzyme Inhibitors; Ergolines; Female; Follow-Up Studies; Hirsutism; Hormone Antagonists; Hormones; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Ketoconazole; Male; Metyrapone; Middle Aged; Mifepristone; Muscle Weakness; Muscular Atrophy; Neurosurgical Procedures; Obesity, Abdominal; Pituitary ACTH Hypersecretion; Pituitary Irradiation; Polycystic Ovary Syndrome; Retrospective Studies; Rosiglitazone; Somatostatin; Striae Distensae; Thiazolidinediones; Treatment Outcome; Tumor Burden; Young Adult	2017
MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2019, Volume: 25, Issue:8 Topics: Adenoma; Adrenal Gland Neoplasms; Humans; Hydrocortisone; Mifepristone; Pilot Projects; Quality of Life	2019
Studies on the glucocorticoid-receptor blocking action of RU 38486 in cultured ACTH-secreting human pituitary tumour cells and normal rat pituitary cells. Acta endocrinologica, 1985, Volume: 109, Issue:1 Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cells, Cultured; Corticotropin-Releasing Hormone; Dexamethasone; Estrenes; Female; Humans; Mifepristone; Pituitary Gland, Anterior; Pituitary Neoplasms; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Receptors, Steroid	1985
A study of anti-progestational compound RU38486 action on the estrogen-induced enlargement of the rat pituitary gland. Nihon Sanka Fujinka Gakkai zasshi, 1987, Volume: 39, Issue:9 Topics: Adenoma; Animals; Estradiol; Estrenes; Female; Mifepristone; Organ Size; Ovariectomy; Pituitary Gland; Pituitary Neoplasms; Progesterone; Rats; Rats, Inbred Strains; Receptors, Estradiol	1987